Efficacy of Pandughni Vati & Punarnavadi Mandura Vati in the managment of Pandu w.s.r. iron deficiency anemia in children- An open labelled comparative clinical trial.
{"title":"Efficacy of <i>Pandughni Vati</i> & <i>Punarnavadi Mandura Vati</i> in the managment of <i>Pandu</i> w.s.r. iron deficiency anemia in children- An open labelled comparative clinical trial.","authors":"V K Kori, K S Patel","doi":"10.4103/ayu.AYU_206_20","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Anemia is a public health problem worldwide, and its prevalence in India is higher than any other south asian countries. Iron deficiency anemia (IDA) is having larger share out of all types of anaemia's. Symptomatology of IDA resembles with <i>Kapha</i> dominant variety of <i>Pandu</i>. <i>Pandughni</i> <i>Vati</i> (PV) and <i>Punarnavadi</i> <i>Mandura</i> (PM) <i>Vati</i> mentioned in Ayurveda are being used in clinical practice since long.</p><p><strong>Aim: </strong>To assess the efficacy of <i>Pandughni</i> <i>Vati</i> and compare its clinical efficacy with <i>Punarnavadi Mandura Vati</i> in the management of <i>Pandu</i> ws.r. iron deficiency anemia in children.</p><p><strong>Materials and methods: </strong>Present clinical study was a randomized trial for management of iron deficiency anemia aged 2-16 years. Out of total 91 patients enrolled, 60 completed the study and divided into two groups. In group A, <i>Pandughni Vati</i> (trial drug) and in group B, <i>Punarnavadi Mandura Vati</i> in the management of <i>Pandu</i> ws.r. iron deficiency anemia in children. (standard drug) were given to 30-30 patients respectively for a duration of 90 days in age specific doses. Patients were assessed by clinical signs and symptoms of <i>Pandu</i> and investigation parameters like complete blood count, serum iron, serum ferritin and total iron binding capacity (TIBC) on baseline and after 90 days of treatment. Statistical analysis was carried out by Sigma Stat software.</p><p><strong>Results: </strong>On comparison, highly significant difference was found between two groups in subjective parameters such as <i>Panduta</i> (pallor), <i>Daurbalya</i> (weakness), <i>Hriddrava</i> (palpitation), <i>Akshikuta Shotha</i> (periorbital oedema), <i>Pindikodweshtana</i> (leg cramps) and <i>Shwasa</i> (breathlessness) whereas objective and saturation percentage except serum ferritin.</p><p><strong>Conclusion: </strong>The study revealed that, both the drugs; <i>Pandughni Vati</i> and <i>Punarnavadi Mandura Vati</i> were equally effective in the management of IDA so, it could be concluded that <i>Pandughni Vati</i>, can be used as mineral-free, safe, easily obtainable, palatable, cost-effective alternative drug of choice in alternative of <i>Punarnavadi Mandura</i> in iron deficiency anemia in children.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4d/4a/AYU-41-218.PMC9261995.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ayu","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ayu.AYU_206_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Anemia is a public health problem worldwide, and its prevalence in India is higher than any other south asian countries. Iron deficiency anemia (IDA) is having larger share out of all types of anaemia's. Symptomatology of IDA resembles with Kapha dominant variety of Pandu. PandughniVati (PV) and PunarnavadiMandura (PM) Vati mentioned in Ayurveda are being used in clinical practice since long.
Aim: To assess the efficacy of PandughniVati and compare its clinical efficacy with Punarnavadi Mandura Vati in the management of Pandu ws.r. iron deficiency anemia in children.
Materials and methods: Present clinical study was a randomized trial for management of iron deficiency anemia aged 2-16 years. Out of total 91 patients enrolled, 60 completed the study and divided into two groups. In group A, Pandughni Vati (trial drug) and in group B, Punarnavadi Mandura Vati in the management of Pandu ws.r. iron deficiency anemia in children. (standard drug) were given to 30-30 patients respectively for a duration of 90 days in age specific doses. Patients were assessed by clinical signs and symptoms of Pandu and investigation parameters like complete blood count, serum iron, serum ferritin and total iron binding capacity (TIBC) on baseline and after 90 days of treatment. Statistical analysis was carried out by Sigma Stat software.
Results: On comparison, highly significant difference was found between two groups in subjective parameters such as Panduta (pallor), Daurbalya (weakness), Hriddrava (palpitation), Akshikuta Shotha (periorbital oedema), Pindikodweshtana (leg cramps) and Shwasa (breathlessness) whereas objective and saturation percentage except serum ferritin.
Conclusion: The study revealed that, both the drugs; Pandughni Vati and Punarnavadi Mandura Vati were equally effective in the management of IDA so, it could be concluded that Pandughni Vati, can be used as mineral-free, safe, easily obtainable, palatable, cost-effective alternative drug of choice in alternative of Punarnavadi Mandura in iron deficiency anemia in children.